Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 65501 - 65525 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Resveratrol	Investigational	PHTF2	57157	upregulated	resveratrol results in increased expression of PHTF2 mRNA	7q11.23-q21.11	A21103
Resveratrol	Investigational	PIAS3	10401	upregulated	resveratrol results in increased expression of PIAS3 mRNA	1q21.1	A23913 A23883
Resveratrol	Investigational	PIDD1	55367	upregulated	resveratrol results in increased expression of PIDD1 mRNA	11p15.5	A23867
Resveratrol	Investigational	PIK3CB	5291	downregulated	resveratrol results in decreased expression of PIK3CB mRNA	3q22.3	A23854
Resveratrol	Investigational	PIK3R1	5295	upregulated	resveratrol results in increased expression of PIK3R1 mRNA	5q13.1	A23858
Resveratrol	Investigational	PIM1	5292	upregulated	resveratrol results in increased expression of PIM1 mRNA	6p21.2	A22823
Resveratrol	Investigational	PKM	5315	downregulated	[resveratrol results in decreased activity of MTOR protein] which results in decreased expression of PKM mRNA	15q23	A23997
Resveratrol	Investigational	PKN2	5586	downregulated	resveratrol results in decreased expression of PKN2 mRNA	1p22.2	A23858
Resveratrol	Investigational	PLA2G6	8398	upregulated	resveratrol results in increased expression of PLA2G6 mRNA	22q13.1	A23857
Resveratrol	Investigational	PLAT	5327	upregulated	resveratrol results in increased expression of PLAT mRNA	8p11.21	A23808
Resveratrol	Investigational	PLAU	5328	downregulated	resveratrol results in decreased expression of PLAU mRNA	10q22.2	A23998 A23999 A24000
Resveratrol	Investigational	PLAU	5328	upregulated	resveratrol results in increased expression of PLAU mRNA	10q22.2	A23808
Resveratrol	Investigational	PLAUR	5329	downregulated	resveratrol results in decreased expression of PLAUR mRNA	19q13	A23998 A24000
Resveratrol	Investigational	PLCG1	5335	downregulated	resveratrol results in decreased expression of PLCG1 mRNA	20q12	A23847
Resveratrol	Investigational	PLK1	5347	downregulated	resveratrol results in decreased expression of PLK1 mRNA	16p12.2	A23857
Resveratrol	Investigational	PLOD3	8985	upregulated	resveratrol results in increased expression of PLOD3 mRNA	7q22.1	A21627
Resveratrol	Investigational	PLP2	5355	upregulated	resveratrol results in increased expression of PLP2 mRNA	Xp11.23	A22498
Resveratrol	Investigational	PLPPR2	64748	upregulated	resveratrol results in increased expression of PLPPR2 mRNA	19p13.2	A22289
Resveratrol	Investigational	PLXDC1	57125	upregulated	resveratrol results in increased expression of PLXDC1 mRNA	17q12	A23845
Resveratrol	Investigational	PLXDC2	84898	upregulated	resveratrol results in increased expression of PLXDC2 mRNA	10p12.31	A22289
Resveratrol	Investigational	PMAIP1	5366	upregulated	resveratrol results in increased expression of PMAIP1 mRNA	18q21.32	A23867
Resveratrol	Investigational	PMEPA1	56937	downregulated	resveratrol results in decreased expression of PMEPA1 mRNA	20q13.31	A21310 A21103
Resveratrol	Investigational	PML	5371	upregulated	resveratrol results in increased expression of PML mRNA	15q24.1	A23845
Resveratrol	Investigational	PMS1	5378	downregulated	resveratrol results in decreased expression of PMS1 mRNA	2q32.2	A23852
Resveratrol	Investigational	PNPLA5	150379	upregulated	resveratrol results in increased expression of PNPLA5 mRNA	22q13.31	A22289

Displaying entries 65501 - 65525 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability